McIntyre, DJ; Robinson, SP; Howe, FA; Griffiths, JR; Ryan, AJ; Blakey, DC; Peers, IS; Waterton, JC
(2004)
Single dose of the antivascular agent, ZD6126 (N-acetylcoichinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model.
NEOPLASIA, 6 (2).
150 - 157 (8).
ISSN 1522-8002
https://doi.org/10.1593/neo.03247
SGUL Authors: Howe, Franklyn Arron
Item Type: | Article |
---|---|
Additional Information: | PubMed ID: 15140404 |
Keywords: | Animals, Disease Models, Animal, Magnetic Resonance Imaging, Necrosis, Neovascularization, Pathologic, Organophosphorus Compounds, Pituitary Neoplasms, Prolactinoma, Rats, Rats, Inbred WF, Regional Blood Flow, Science & Technology, Life Sciences & Biomedicine, Oncology, ZD6126, vascular targeting, therapy, cancer, MRI, VASCULAR-TARGETING AGENT, BLOOD-FLOW, THERAPY, GROWTH, ZD6126, vascular targeting, therapy, cancer, MRI |
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Neuroscience (INCCNS) |
Journal or Publication Title: | NEOPLASIA |
ISSN: | 1522-8002 |
Related URLs: | |
Web of Science ID: | WOS:000221133400007 |
![]() ![]() |
Download EPMC Full text (PDF) |
![]() |
Download EPMC Full text (HTML) |
URI: | https://openaccess.sgul.ac.uk/id/eprint/146 |
Publisher's version: | https://doi.org/10.1593/neo.03247 |
Actions (login required)
![]() |
Edit Item |